elevated lipase with glp-1 Suspected drug-induced pancreatitis was rare but more common in patients taking agonists than sulfonylureas, a recent analysis of a VA database finds Adverse effects of GLP-1 class

The contents of this website are not intended to substitute for professional medical advice, diagnosis or treatment

These findings point to broader experimental uses beyond diabetes models

But the injectable has some additional benefits

Options include manufacturer cash-pay programs (Eli Lilly Direct for Zepbound, Novo Nordisk programs for Wegovy), commercial savings cards if eligible, alternative FDA-approved weight loss medications such as Contrave or Qsymia, or making the case to your employers HR or benefits committee that the exclusion be reconsidered

Planned follow-up visits required to assess adherence and clinical response